The consumer goods giant’s performance has been in a funk for a long time. Fund managers need to stop giving it a long rope.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
The recent spat between the two brands brings to the fore the stiff competition in the largely unregulated skincare industry.
No matter how good a business, overpaying for a stock negatively impacts returns. Saurabh Mukherjea’s Marcellus is only the latest example of the perils of forgetting this timeless lesson.
Startups and legacy FMCG players are increasingly launching packaged food rich in protein, but rampant misselling is spoiling the party.